6
Linking Drug Stability to Manufacturing Risk Assessment Approaches L. E. Kirsch Stability team leader

Linking Drug Stability to Manufacturing Risk Assessment Approaches

Embed Size (px)

DESCRIPTION

Linking Drug Stability to Manufacturing Risk Assessment Approaches. L. E. Kirsch Stability team leader. Stability in Design Space. L t End of Expiry. Post-Manuf. Kinetic Model. Manuf. Design Space Model. L 0 D 0. Manufacturing stability measurements: criteria and uses - PowerPoint PPT Presentation

Citation preview

Page 1: Linking Drug Stability to Manufacturing Risk Assessment Approaches

Linking Drug Stability to ManufacturingRisk Assessment Approaches

L. E. KirschStability team leader

Page 2: Linking Drug Stability to Manufacturing Risk Assessment Approaches

2

Stability in Design Space

• Manufacturing stability measurements: criteria and uses1. Rationality based on understanding of instability2. Correlates to shelf-life3. Correlates to risk: failure to reach desired shelf-

life without exceeding critical instability target

Post-Manuf.Kinetic Model

Lt

End of

Expiry

Manuf. Design Space Model

L0

D0

Page 3: Linking Drug Stability to Manufacturing Risk Assessment Approaches

Correlation between Shelf-life and Manufacturing-stability Measurements

(preliminary long term stability studies)

Shelf-life estimated fromlinear extrapolation of roomtemperature stability data

1

2

3

4

5

6

0 0.05 0.1 0.15 0.2 0.25 0.3

Ext

rap

ola

ted

Sh

elf-

life

(yea

rs)

D0 + L

0 (mole %)

Page 4: Linking Drug Stability to Manufacturing Risk Assessment Approaches

Logistical Regression Model for Stability Risk Assessment

• Shelf-life = Time to 0.4 % lactam (linear extrapolation of long-term stability

data)• Stability failure: Shelf-life < Desired target dating (e.g. 2 years)• Logistical Regression model:

– probability of stability failure as a function of the manufacturing-stability measurements (L0 and D0, mole %)

fail

ure

pro

b

0.00

0.25

0.50

0.75

1.00

.175 .200 .225 .250 .275 .300

D0 + L0

0

1

Page 5: Linking Drug Stability to Manufacturing Risk Assessment Approaches

5

Estimated Stability Risk application of logistical regression model

0.001 0.01 0.1 1 10 100

APIAPIAPI

BLENDBLENDBLENDBLENDBLEND

GRANULATIONGRANULATIONGRANULATIONGRANULATIONGRANULATIONGRANULATIONGRANULATIONGRANULATIONGRANULATIONGRANULATION

MILLINGMILLINGMILLINGMILLINGMILLINGMILLINGMILLINGMILLINGMILLINGMILLINGMILLING

Risk of Shelf-life Failure (%)

Lab Bench Lots Lab Pilot Lots

0.01 0.1 1 10 100

BLENDINGBLENDINGBLENDING

DRYINGDRYINGDRYINGDRYINGDRYINGDRYING

GRANULATIONGRANULATIONGRANULATIONGRANULATIONGRANULATION

TABLETTABLETTABLETTABLETTABLETTABLETTABLETTABLETTABLETTABLETTABLETTABLETTABLETTABLETTABLETTABLETTABLETTABLETTABLETTABLETTABLETTABLET

Risk of Shelf-life Failure (%)

Page 6: Linking Drug Stability to Manufacturing Risk Assessment Approaches

Long-term stability• Objectives

1. Demonstrate relationship between Manufacturing-related stability measurement (MSM: D0 and L0) and shelf-life

2. Demonstrate/validate solid state degradation model

3. Construct definitive “Risk-based” Design Space Models

• Current state– Studies underway